Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Bases of Response to Copper Treatment in Menkes Disease, Related Phenotypes, and Unexplained Copper Deficiency

NCT00811785 is registered in ClinicalTrials.gov with Cyprium Therapeutics, Inc. as lead sponsor.

NCT NCT00811785
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00811785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Bases of Response to Copper Treatment in Menkes Disease, Related Phenotypes, and Unexplained Copper Deficiency
Lead sponsor
Cyprium Therapeutics, Inc.
Phase
Phase 3
Overall status
Completed
Start date
February 27, 2009
Completion date
August 28, 2020
Enrollment
93 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

menkes disease, occipital horn syndrome, unexplained copper deficiency